Target (CBDY) Debt to Equity (2015 - 2026)

Target (CBDY) reported Debt to Equity of -$0.0 for Q1 2026, up 65.84% year-over-year from -$0.0 in Q1 2025, and up 5.12% quarter-over-quarter from -$0.0 in Q4 2025.

Target (CBDY) Debt to Equity (2015 - 2026) Analysis & Trends

Target (CBDY) has 12 years of Debt to Equity data on file, last reported at -$0.0 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at -$0.0, up 65.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.0 (up 65.84% YoY), and the FY2025 annual result was -$0.0, up 18.3% from the prior year.
  • Debt to Equity advanced to -$0.0 in Q1 2026 per CBDY's latest filing, from -$0.0 in the prior quarter.
  • Over five years, Debt to Equity peaked at -$0.0 in Q1 2026 and troughed at -$0.0 in Q3 2022.
  • A 5-year average of -$0.0 and a median of -$0.0 in 2025 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2024 and 2025: Debt to Equity jumped 67.66% in 2024, then slumped 147.5% in 2025.
  • A 5-year view of Debt to Equity shows it stood at -$0.0 in 2022, then jumped by 50.11% to -$0.0 in 2023, then dropped by 6.32% to -$0.0 in 2024, then grew by 18.3% to -$0.0 in 2025, then rose by 5.12% to -$0.0 in 2026.
  • Business Quant data shows CBDY's Debt to Equity at -$0.0 in Q1 2026, -$0.0 in Q4 2025, and -$0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 2.02
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.80
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.61
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.86
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.47
10 Target - - 191,787.00 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2021 0.00
Mar 31, 2021 -0.01
Dec 31, 2020 0.00
Sep 30, 2020 0.01
Jun 30, 2020 0.00